Overview

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Status:
Terminated
Trial end date:
2016-11-04
Target enrollment:
Participant gender:
Summary
This phase II trial studies the effects of interstitial photodynamic therapy in patients with head and neck cancer that has come back. Interstitial photodynamic therapy uses a combination of laser light and a light-sensitive drug called porfimer sodium to destroy tumors. During treatment a laser light is used to activate the drug. Interstitial photodynamic therapy may be an effective treatment for head and neck cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Roswell Park Cancer Institute
Collaborator:
National Cancer Institute (NCI)
Treatments:
Dihematoporphyrin Ether
Trioxsalen